Information on medicinal products affecting the renin-angiotensin system: Key elements for communication
2014.12.01
Active substance: ACE-Hemmer, Angiotensin-II-Rezeptor-Antagonisten, Aliskiren
The Pharmacovigilance Risk Assessment Committee (PRAC) has adopted key elements regarding communication of the outcome of the safety review regarding medicinal products that affect the renin-angiotensin system.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN